Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
978
-
Total shares
-
123M
-
Shares change
-
-2.97M
-
Total reported value, excl. options
-
$35B
-
Value change
-
-$824M
-
Put/Call ratio
-
1.09
-
Number of buys
-
390
-
Number of sells
-
-437
-
Price
-
$284.85
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q2 2023
1,014 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q2 2023.
BIOGEN INC. - Common Stock (BIIB) has 978 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 147M outstanding shares and own 83.55% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16M shares), BlackRock Inc. (14.1M shares), VANGUARD GROUP INC (12.2M shares), STATE STREET CORP (6.89M shares), WELLINGTON MANAGEMENT GROUP LLP (5.35M shares), JPMORGAN CHASE & CO (4.47M shares), T. Rowe Price Investment Management, Inc. (3.4M shares), GEODE CAPITAL MANAGEMENT, LLC (3.18M shares), FMR LLC (2.64M shares), and Clearbridge Investments, LLC (1.83M shares).
This table shows the top 978 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.